Viking Therapeutic (VKTX) PT Lowered to $22.50 at Roth Capital
Tweet Send to a Friend
Roth Capital analyst Scott R. Henry lowered the price target on Viking Therapeutic (NASDAQ: VKTX) to $22.50 (from $24.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
